Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5594
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma ; day:7 ; month:6 ; year:2018 ; pages:1-15
Oncogene ; (7.6.2018), 1-15
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Boboila, Shuobo
- Beteiligte Personen und Organisationen
-
Lopez, Gonzalo
Yu, Jiyang
Banerjee, Debarshi
Kadenhe-Chiweshe, Angela
Connolly, Eileen P.
Kandel, Jessica J.
Rajbhandari, Presha
Silva, Jose M.
Califano, Andrea
Yamashiro, Darrell J.
SpringerLink (Online service)
- DOI
-
10.1038/s41388-018-0326-9
- URN
-
urn:nbn:de:101:1-2018081216384579211768
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Boboila, Shuobo
- Lopez, Gonzalo
- Yu, Jiyang
- Banerjee, Debarshi
- Kadenhe-Chiweshe, Angela
- Connolly, Eileen P.
- Kandel, Jessica J.
- Rajbhandari, Presha
- Silva, Jose M.
- Califano, Andrea
- Yamashiro, Darrell J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma
Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma
The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells
Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells
Identification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma
The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma
Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma
The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells
Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells
Identification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma
The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma
Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma
The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells
Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells
Identification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma